Results

1–10 of 66 results for PDR

Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-Release Axitinib Implant (OTX-TKI) for NPDR
Dilsher S. Dhoot, MD
Annual Meeting Talks
2024
Shooting Stars
Majda Hadziahmetovic, MD
Retina Image Bank: Images of the Week
2025
Aurora Borealis in Retina
Poornachandra B, MS, FVRS
Naresh Kumar Yadav, FRCS
Retina Image Bank: Images of the Week
2025
Who Stole My Blood Supply?
Muna Bhende, MD
Pramod S. Bhende, M S
Retina Image Bank: Images of the Week
2025
Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
Annual Meeting Talks
2022
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023
A Nightmare on PDR-TRD Street
On Demand Cases, Courses, and Papers
2022
High risk Proliferative Diabetic Retinopathy treated with Pan Retinal Photocoagulation
Somnath Chakraborty, MD
Retina Image Bank: Images of the Week
2022
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
On Demand Cases, Courses, and Papers
2021
Aflibercept Versus Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
On Demand Cases, Courses, and Papers
2021